Aktuelle Trends in der Arzneimitteldistribution: Welche innovativen Distributionswege sind denkbar?
07/26/2010
Rate this Video:
(Be the First!)
Hans-Peter Getrost | arzneimitteldistribution | pharma distribution | European distribution | warehouse management | good distribution practice | 3rd party integration | DTP | direct to pharmacy | innovative pharma distribution | European Hub Model | Direct-to-Patient | value added services
Hans-Peter Getrost | arzneimitteldistribution | pharma distribution | European distribution | warehouse management | good distribution practice | 3rd party integration | DTP | direct to pharmacy | innovative pharma distribution | European Hub Model | Direct-to-Patient | value added services
Arzneimitteldistribution in Deutschland eine Bestandsaufnahme
Einfluss der 15. AMG-Novelle auf die Arneimittel-Belieferung in Deutschland
Ausblick
-
Improving Processes and Delivering Business Benefits Through QbD: Milling of an API -
Building Quality from the Beginning -
Laurel LaBauve Speaks about Merck Sigma -
Using Lean Six Sigma to Benefit Pharmaceutical Sales and Marketing and R&D -
Formulations for Toxicology Studies -
Die veränderten Rahmenbedingungen aus Sicht der Hersteller Auswirkungen und Handlungsoptionen -
Getting the Best Out of Your CRO: Best Practice Techniques for Small Companies -
Risk Management in IT Outsourcing: The Shared Stake Perspective in Multinational Corporations -
Best Practice Strategies for Managing CROs -
Interview mit Eberhard Lüdtke, Lundbeck GmbH
You Should Check Out:
* = required.
Not a member yet? Sign up
Events of Interest
-
Konsequenzen der Arzneimittelmarktreform
Grand Hotel Esplanade Berlin, Berlin, Deutschland
September 27- 29, 2010 -
GCP, Auditing and Compliance
St Ermin’s Hotel, London
November 29- 1, 2010 -
Global Corruption and Bribery Compliance for Life Sciences
The Marriott Hotel Marble Arch, London
November 29- 1, 2010 -
Bioavailability and Bioequivalence
Venue to be confirmed, Munich, Germany
October 26- 27, 2010
You Might Also Like
-
Was sind die Herausforderungen auf der letzten Meile zum Patienten?
In diesem Interview spricht Walter Heider, Director Commercial Department und Business Development bei der
Pharma IQ
-
Die veränderten Rahmenbedingungen aus Sicht der Hersteller Auswirkungen und Handlungsoptionen
Der vollversorgende herstellerneutrale Pharmagroßhandel in Deutschland Europa und die 15. AMG-Novelle
-
Will a Centralised DC Help Lower Inventory Levels?
The conventional wisdom on inventory management is that centralising inventory in a single place will lower...Read more
Jim Panos
-
Career Spotlight: Pharma Regulatory Affairs
Pharma regulatory affairs professionals play an essential role in ensuring all pharmaceutical products...Read more
Pharma IQ
